Ocumension

Ocumension Therapeutics is a Chinese ophthalmic pharmaceutical platform company dedicated to identifying, developing, and commercializing first-in-class or best-in-class ophthalmic therapies. Their vision is to provide world-class comprehensive drug solutions to address the significant unmet needs in China's ophthalmic healthcare sector. Since its establishment, the company has focused on building an ophthalmic pharmaceutical platform that integrates professional capabilities across the entire lifecycle of ophthalmic drug development, from R&D and manufacturing to commercialization. They believe their platform positions them advantageously on the path to becoming a leader in China's ophthalmic industry, with a first-mover advantage over future competitors.